tiprankstipranks
Advertisement
Advertisement
Jazz Pharmaceuticals Balances Record Gains With Slower 2026
PremiumCompany AnnouncementsJazz Pharmaceuticals Balances Record Gains With Slower 2026
1M ago
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
Premium
The Fly
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
1M ago
Jazz Pharmaceuticals Advances ONC206 Trial in Rare Tumors, Offering a New Pipeline Catalyst for JAZZ
Premium
Company Announcements
Jazz Pharmaceuticals Advances ONC206 Trial in Rare Tumors, Offering a New Pipeline Catalyst for JAZZ
1M ago
Jazz Pharmaceuticals price target raised to $250 from $235 at Wells Fargo
PremiumThe FlyJazz Pharmaceuticals price target raised to $250 from $235 at Wells Fargo
1M ago
Jazz Pharmaceuticals: Underappreciated Growth Story with Durable Sleep Franchise and Pipeline-Driven Upside
Premium
Ratings
Jazz Pharmaceuticals: Underappreciated Growth Story with Durable Sleep Franchise and Pipeline-Driven Upside
1M ago
Jazz Pharmaceuticals reports Q4 adjusted EPS $6.64 vs. $6.51 last year
Premium
The Fly
Jazz Pharmaceuticals reports Q4 adjusted EPS $6.64 vs. $6.51 last year
1M ago
Jazz Pharmaceuticals price target raised to $230 from $220 at Truist
PremiumThe FlyJazz Pharmaceuticals price target raised to $230 from $220 at Truist
3M ago
Jazz Pharmaceuticals price target raised to $235 from $210 at Needham
Premium
The Fly
Jazz Pharmaceuticals price target raised to $235 from $210 at Needham
3M ago
Jazz Pharmaceuticals price target raised to $235 from $210 at Needham
Premium
The Fly
Jazz Pharmaceuticals price target raised to $235 from $210 at Needham
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100